Published in Genetics and Environmental Business Week, August 13th, 2009
"The aim of this study was to investigate the role of TCBF and CVR in the progression of MR imaging abnormalities in CADASIL. Basal TCBF was measured in 25 NOTCH3 mutation carriers and 13 control subjects at baseline. CVR after administration...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.